About Erica Joyner

This author has not yet filled in any details.
So far Erica Joyner has created 377 blog entries.

Arizona

On March 30, Gov. Doug Ducey (R) signed HB 2490 (Chapter 98), providing clarity for collaborative practice agreements including requirements, rules, and definitions.

Also in Arizona, on March 24, Gov. Doug Ducey (R) signed HB 2612 (Chapter 59), removing certain occupational licensing requirements and regulations that applicants/persons must be “of good moral character” to be approved for certain licenses and certifications including pharmacists and pharmacy technicians.

Finally, in Arizona, on March 25, Gov. Doug Ducey (R) signed SB 1639 (Chapter 78), that requires integrating a medical practitioner’s electronic medical records system with the state’s Controlled Substances Prescription Monitoring Program (CSPMP) central database tracking system either directly or through the statewide health information exchange or a third-party vendor, by December 31, 2026.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2022-04-08T12:18:34-04:00April 8, 2022|Arizona|

California

As a reminder regarding the COVID-19 declaration of emergency, the Board of Pharmacy has a webpage dedicated to Pharmacy Law Waivers; interested parties may sign up to receive the Board’s alerts for the most up-to-date information. Also, the Department of Consumer Affairs (DCA) has a webpage dedicated to DCA Waivers and Guidance Documents..

Also in California, as a reminder, the Department of Health Care Services (DHCS) eased DUR edits in Medi-Cal Rx until May 1. NACDS and the California Retailers Association have been in communication with the DHCS staff to request advance notice be provided to pharmacy providers of the Department’s plans for these DUR edits in advance of May 1.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2022-04-08T12:17:37-04:00April 8, 2022|California|

Georgia

The Georgia Board of Pharmacy is excited to announce and introduce the first installment of a new “Newsletter.” The newsletter will be produced on a quarterly basis and is intended to provide insights and updates on the profession of pharmacy in Georgia. The newsletter will also be posted on the GBOP website for easy access as well. Since the newsletter is a new resource, the Board asks that you please distribute it to others in your organization or staff.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-04-08T12:16:40-04:00April 8, 2022|Georgia|

Iowa

The Board of Pharmacy published the following Notices of Intended Action. Written comments may be submitted until 4:30 p.m. on April 26. A public hearing will be held at 10:00 a.m. on April 27 at the offices of the Board and via Zoom.

  • ARC 6279C– amending Chapter 3, “Pharmacy Technicians” and Chapter 6, “General Pharmacy Practice to permit remote processing
  • ARC 6280C – amending Chapter 12, “Precursor Substances” to add one chemical as a precursor substance in response to similar action taken by the DEA.
  • ARC 6182C – amending Chapter 8, “Universal Practice Standards,” and Chapter 19, “Nonresident Pharmacy Practice” to provide modification of the handling of ownership changes, add requirements for nonresident pharmacies and other changes.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2022-04-08T12:15:04-04:00April 8, 2022|Iowa|

Missouri

In advance of the April 12th Senate Insurance and Banking hearing on HCR HB 1677, NACDS submitted a letter supporting certain provisions of the legislation that would strengthen Missouri’s PBMs laws to enhance patients’ ability to receive pharmacy care from their pharmacy of choice and improve provisions for fair and equitable standards for the management of pharmacy benefits. In our letter, NACDS specifically called out support for the provisions that would prohibit PBMs from preventing, penalizing or restricting patients’ ability to obtain services from a contracted pharmacy; the provisions that would enhance the appeals process to requiring PBMs to increase a pharmacy’s reimbursement in instances when reimbursement is found to be below a pharmacy’s cost for purchasing a drug; and the provisions that would prevent PBMs from imposing unwarranted fees on claims related to administering a health plan.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2022-04-08T12:14:15-04:00April 8, 2022|Missouri|

Nebraska

Executive Order No. 22-02 — Continued Waivers to Facilitate Hospital Planning and Ensure Additional Healthcare Workforce Capacity — states “Executive Order No. 21-15, which is currently scheduled to expire on March 31, 2022, per [E]xecutive [O]rder No. 21-18, shall remain in effect through September 30, 2022.” See item 6 in Executive Order No. 21-15 suspending Neb. Rev. Stat. § 38-2866.01 and its implementing regulations “in order to permit pharmacists to have any number of pharmacist interns and pharmacy technicians under their supervision insofar as they determine it necessary within their professional discretion when administering vaccinations”.

Also in Nebraska, the Department of Health and Human Services announced the next COVID-19 Medicaid Provider call will take place on May 4 at noon (Central).

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2022-04-08T12:13:10-04:00April 8, 2022|Nebraska|

New York

The State Education Department regulation expanding the pharmacist immunization authority which took effect on January 31, 2022, is set to expire on April 10. At the last Board of Regents meeting, the Board took emergency action effective April 11 to keep the regulation in effect until it can be permanently adopted at the Board May Meeting.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

2022-04-08T12:12:02-04:00April 8, 2022|New York|

North Carolina

SPECIAL BULLETIN COVID-19 #242: Continued Reimbursement for COVID-19-Related Services for the Uninsured. Effective April 4, 2022

NC Medicaid continues to reimburse providers for COVID-19 related services for the NC Medicaid Optional Eligibility Group (which includes the uninsured (MCV) and MAFDN Family Planning Group). This program was initiated in 2020 for COVID-19 and expanded by the America Rescue Plan Act to include COVID-19 treatment and vaccination. NC Medicaid will continue to operate this program through the federal public health emergency.

It was recently announced that the Health Resources and Services Administration (HRSA) -led initiative to reimburse for COVID-19 testing and treatment will end. This program also reimbursed health care providers for delivering COVID-19 testing, treatment and vaccines to those without health insurance. As of March 22, 2022, the program stopped accepting claims for testing and treatment services. On April 5, 2022, the program will stop accepting claims for vaccine administration.

This bulletin services as a reminder that the two programs are separate entities, and that NC Medicaid will continue to reimburse providers who deliver COVID-19 treatment, testing, and vaccine administration for the uninsured in the state. To be eligible for the program, individuals must:

  1. Enroll in Medicaid for the uninsured (MCV) group or MAFDN Family Planning.
  2. Be uninsured.
  3. Be a resident of North Carolina.
  4. Meet the citizenship and legal immigration status requirements of the Medicaid program.

Detailed eligibility requirements may be found in SPECIAL BULLETIN COVID-19 #206.

Also in North Carolina, The Board of Pharmacy has completed a rulemaking to amend Rule .1816, now titled “Centralized Pharmacy Services.” The amended rule broadens the availability of remote medication order processing (“RMOP”) arrangements among pharmacies to all pharmacy practice types. The full rule is found here: 21 NCAC 46.1816

The new RMOP provisions became effective March 1, 2022. However, the Board’s Expanded Emergency Services Waiver, issued on March 17, 2020, because of the COVID-19 public health emergency, authorized expanded RMOP arrangements: Expanded Emergency Services Waiver

Pharmacies may continue to operate RMOP arrangements pursuant to the waiver until June 1, 2022. Beginning June 1, 2022, the Board will enforce the Rule .1816-based RMOP requirements. To assist pharmacies transitioning to the rule based RMOP requirements, Board staff have prepared two guidance documents.

The first, http://www.ncbop.org/PDF/GuideToInterPharmacyRMOP.pdf – provides a detailed overview of the revised rule governing inter-pharmacy RMOP arrangements. Please note, this guidance document only concerns RMOP services arranged between two pharmacies. The Board has proposed a new rule (Proposed New Rule 21 NCAC 46.2515) authorizing intra-pharmacy remote services (i.e., a pharmacy uses its own personnel to provide off-site services). Once that rulemaking is complete, the Board staff will provide a separate guidance document on that topic. In the meantime, intra-pharmacy remote services are allowed under the Expanded Emergency Services Waiver linked above.

The second, http://www.ncbop.org/PDF/HowToRegisterAsNABPVerifyHolder.pdf – provides detailed instructions on how out-of-state pharmacists who are performing RMOP services and who are not individually licensed to practice pharmacy in North Carolina may obtain an NABP Verify credential and register with the Board of Pharmacy, as required by revised Rule .1816.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-04-08T12:10:37-04:00April 8, 2022|North Carolina|

North Dakota

The Department of Health has developed the following COVID-19 vaccine resources:

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2022-04-08T12:07:30-04:00April 8, 2022|North Dakota|
Go to Top